[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339385-105":59,"doc-detail-339385-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-analysis-of-single-cell-and-bulk-rna-sequencing-data-reveals-a-myeloid-cell-related-regulon-predicting-neoadjuvant-immunotherapy-response-across-cancers","Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers","","Immunotherapy has changed cancer treatment, yet many patients resist or become refractory while the biological mechanisms remain insufficiently explained. This study integrates pre- and post–neoadjuvant immunotherapy single-cell RNA-seq from lung adenocarcinoma patients achieving pathological complete response with pySCENIC-based gene regulatory network inference. A myeloid-associated regulon predicting immune checkpoint inhibitor response is identified and validated across pan-cancer single-cell and bulk transcriptomic cohorts, supported by a myeloid cell map and PPARG high-expression subclusters.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-analysis-of-single-cell-and-bulk-rna-sequencing-data-reveals-a-myeloid-cell-related-regulon-predicting-neoadjuvant-immunotherapy-response-across-cancers/339385/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-analysis-of-single-cell-and-bulk-rna-sequencing-data-reveals-a-myeloid-cell-related-regulon-predicting-neoadjuvant-immunotherapy-response-across-cancers/339385.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study trying to address about immunotherapy in cancer?","Question",{"text":112,"@type":113},"The study targets the problem that most patients show resistance or later refractoriness to immunotherapy, with the underlying mechanisms still not fully understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the gene regulatory network analysis performed?",{"text":117,"@type":113},"Single-cell RNA-seq datasets from pre- and posttreatment samples were collected, and pySCENIC was used to identify gene regulatory networks between cell types and immune checkpoint inhibitor response.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biomarker and supporting resources did the study produce?",{"text":121,"@type":113},"A myeloid cell-related PPARG regulon was associated with ICI response and validated across multiple pan-cancer cohorts. The work also developed a myeloid cell map and a PPARG website to support discovery using public scRNA-seq data.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339385,1790167298,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Liu et al. Journal of Translational Medicine (2024) 22:486  \n[https://doi.org/10.1186/s12967-024-05123-9](https://doi.org/10.1186/s12967-024-05123-9)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nIntegrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cellrelated regulon predicting neoadjuvant immunotherapy response across cancers  \nHong Liu 1†, Xiaoxian Sima 1†, Bijing Xiao 1†, Haimiti Gulizeba 1, Shen Zhao 1*, Ting Zhou 1* and Yan Huang 1*  \nAbstract  \nBackground Immunotherapy has brought about a paradigm shift in the treatment of cancer. However, the majority of patients exhibit resistance or become refractory to immunotherapy, and the underlying mechanisms remain to be explored.  \nMethods Sing-cell RNA sequencing (scRNA-seq) datasets derived from 1 pretreatment and 1 posttreatment achieving pathological complete response (pCR) patient with lung adenocarcinoma (LUAD) who received neoadjuvant immunotherapy were collected, and pySCENIC was used to find the gene regulatory network (GRN) between cell types and immune checkpoint inhibitor (ICI) response. A regulon predicting ICI response was identified and validated using large-scale pan-cancer data, including a colorectal cancer scRNA-seq dataset, a breast cancerscRNA-seq dataset, The Cancer Genome Atlas (TCGA) pan-cancer cohort, and 5 ICI transcriptomic cohorts. Symphony reference mapping was performed to construct the myeloid cell map.  \nResults Thirteen major cluster cell types were identified by comparing pretreatment and posttreatment patients, and the fraction of myeloid cells was higher in the posttreatment group (19 . 0% vs. 11. 8%) . A PPARG regulon (containing 23 target genes) was associated with ICI response, and its function was validated by a colorectal cancer scRNA-seq dataset, a breast cancer scRNA-seq dataset, TCGA pan-cancer cohort, and 5 ICI transcriptomic cohorts. Additionally, a myeloid cell map was developed, and cluster I, II, and III myeloid cells with high expression of PPARG were identified. Moreover, we constructed a website called PPARG ( [https://pparg.online/PPARG/](https://pparg.online/PPARG/ or)[ or](https://pparg.online/PPARG/ or) [http://43.134.20.130:3838/PPARG/](http://43.134.20.130:3838/PPARG/)), which provides a powerful discovery tool and resource value for researchers.  \n†Hong Liu, Xiaoxian Sima and Bijing Xiao contributed equally to this work.  \n*Correspondence:  \nShen Zhao [zhaoshen@sysucc.org.cn](zhaoshen@sysucc.org.cn)[ ](zhaoshen@sysucc.org.cn)Ting Zhou [zhouting@sysucc.org.cn](zhouting@sysucc.org.cn)[ ](zhouting@sysucc.org.cn)Yan Huang [huangyan@sysucc.org.cn](huangyan@sysucc.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nLiu et al. Journal of Translational Medicine (2024) 22:486 Page 2 of 11  \nConclusions The","cbCaihNMxmFnPLsH","https://ap.wps.com/l/cbCaihNMxmFnPLsH","pdf",5999300,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background","[{\"question\":\"What is the study trying to address about immunotherapy in cancer?\",\"answer\":\"The study targets the problem that most patients show resistance or later refractoriness to immunotherapy, with the underlying mechanisms still not fully understood.\"},{\"question\":\"How was the gene regulatory network analysis performed?\",\"answer\":\"Single-cell RNA-seq datasets from pre- and posttreatment samples were collected, and pySCENIC was used to identify gene regulatory networks between cell types and immune checkpoint inhibitor response.\"},{\"question\":\"What key biomarker and supporting resources did the study produce?\",\"answer\":\"A myeloid cell-related PPARG regulon was associated with ICI response and validated across multiple pan-cancer cohorts. The work also developed a myeloid cell map and a PPARG website to support discovery using public scRNA-seq data.\"}]","Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers | PDF",1790029940,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55dff42b6db2c3edb207223814e38927.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6650d7843e964297a82244e338ed6a5f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b89629ebc182ed6f39cdb1d449b8066.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/600790319f229ddb294b48f20fe914d0.webp",980,1306]